Research Focus
Dr. Lucia De Martino’s research centers on pediatric neuro-oncology, particularly focusing on central nervous system (CNS) tumors such as DIPG, medulloblastoma, and ependymoma 🧠🧒. Her research interests include studying molecular markers, biomarkers, and precision therapies to improve diagnosis and treatment outcomes in children. She is involved in several cutting-edge clinical trials, including radiotherapy combined with nimotuzumab and vinorelbine, biobank projects, and retrospective observational studies. Her focus on diffuse midline gliomas with H3 K27M mutation and craniosynostosis-related syndromes aligns with the latest challenges in pediatric oncology. She bridges clinical care and biological research, aiming to personalize treatments and better understand tumor behavior. With a collaborative and multidisciplinary mindset, she contributes to both national registries and global efforts like the SIOPE DIPG Registry and SIOP EP II trials. Her mission is to enhance survival and quality of life for children through science-backed innovations and compassionate care 🧬❤️.
🏅 Awards and Honors
While no formal awards are explicitly listed, Dr. Lucia De Martino’s selection as Principal Investigator and Sub-Investigator on numerous national and international trials is itself a reflection of professional distinction and academic trust 🏆. Being entrusted with leadership roles in landmark studies such as the SIOP DIPG Registry, the International Ependymoma Program, and the Italian Pediatric Thrombosis Registry underlines her recognized expertise and contribution to pediatric oncology. Her participation in high-level training and international congresses — such as SIOP Europe and specialized workshops in pediatric oncology and neurosurgery — further confirms her position as a valued medical researcher. The trust placed in her by leading clinical figures (Dr. Quaglietta, Dr. Cinalli) and institutions like AORN Santobono-Pausilipon and Fondazione IRCCS demonstrates both peer recognition and leadership potential in the field of pediatric neuro-oncology 💫. These roles and appointments are a testament to her clinical excellence and research-driven vision 🧠💡.
🛠️ Skills
Dr. Lucia De Martino possesses a robust blend of clinical, research, and communication skills. Her clinical strengths include pediatric intensive care, neuro-oncology diagnostics, and oncological emergency management 👩⚕️. She is experienced with clinical trials management, including protocol development, data collection, and ethical oversight. She has strong command over digital tools like SPSS IBM, essential for research analysis. Her multilingualism in Italian, English, French, and German facilitates international collaboration 🌍. Additionally, Dr. De Martino is skilled in Good Clinical Practice (GCP) standards and Evidence-Based Medicine (EBM) applications. She thrives in multidisciplinary environments and is adept at translating complex clinical data into actionable treatment plans. Her participation in workshops on neurofibromatosis, pediatric pain, solid tumors, and rare congenital disorders further solidifies her practical expertise. Whether at bedside or in lab meetings, she brings clarity, compassion, and critical thinking to every clinical and academic interaction 🧑🔬💬📊.
Conclusion
Dr. Lucia De Martino demonstrates outstanding dedication to pediatric neuro-oncology, particularly in rare and aggressive brain tumors in children. Her consistent leadership in clinical trials, involvement in high-impact international collaborations, and contributions to translational research mark her as a strong and worthy candidate for the Best Researcher Award.